“Thanks to decades of advances in cancer treatment for young people, adolescents and young adults who survive cancer today can have a full life ahead of them. But maintaining their health over the course of many years requires attentive follow-up care. This study shows we have work to do to ensure more young adult cancer survivors receive the follow-up care they need,” said ASCO Expert Timothy Gilligan, MD, MSc, FASCO, moderator of today’s presscast.
ALEXANDRIA, Va. – A new study suggests that a large percentage of adolescents and young adults (AYAs) who have been treated for cancer do not seek follow-up care after their primary treatment ends, despite its importance for long-term health. AYA cancer survivors are at increased risk for heart problems, infertility, and secondary cancers from cancer treatment.
Nearly half of those diagnosed between 2005-2009 did not seek a follow-up visit with an oncologist in 2016, while a third of those diagnosed between 2010-2014 did not seek follow-up care that same year. These findings will be presented at the upcoming 2018 Cancer Survivorship Symposium in Orlando, Florida.
“Many adolescents and young adults are unaware of what their long-term risks are after they have finished their cancer treatment,” said lead study author Lynda M. Beaupin, MD, an assistant professor of oncology at the Roswell Park Cancer Institute in Buffalo, New York. “Doctors and other health care providers need to be more diligent in letting these patients know about future potential side-effects and health risks that could occur based on certain aspects of their cancer treatment.”
About the Study
In a previous study, the authors held a focus group discussion of 27 AYAs, ages 18 to 39, to query them about the major barriers that prevented them from seeking follow-up care. Among the factors some people mentioned were poor communication with their oncologist, ongoing problems in adjusting to life as a cancer survivor, and loss of health insurance.
As a follow-up to that focus group session, the authors looked at a larger group of AYAs who were treated at Roswell Park Comprehensive Cancer Center by using the institute’s tumor registry, which includes any patient diagnosed with cancer within the cancer center. The data collected for the study included de-identified information on a person’s current age, age at cancer diagnosis, gender, date of diagnosis, date of most recent doctor visit, and type of cancer. The most common types of cancer were leukemia/lymphoma, melanoma, germ cell tumors, and thyroid and breast cancers, which are the most common cancer types in this age group.
The investigators divided the AYAs among the top five cancer types into two groups: 852 people diagnosed between 2010-2014 and 783 people diagnosed between 2005-2009. For their analysis they also included patient-provided information on follow-up doctor appointments and insurance status.
The length of time since their final cancer treatment visit was the most significant factor in not scheduling a follow-up appointment, with 48% of the people in the 2005-2009 group not having a follow-up visit in 2016 vs. 33% of those in the 2010-2014 group not having a visit in 2016. The type of cancer they were treated for did not make a difference in whether a follow-up visit was sought. While health insurance played no role in determining whether the people in the 2005-2009 group sought a follow-up visit, slightly more people without insurance did not schedule follow-up appointments than people with health insurance (39% vs. 33%) in the 2010-2014 group, but that difference was not statistically significant.
The researchers hope to look at other factors that may affect the willingness of AYAs to seek follow-up care in future studies, such as employment status, distance to a cancer center, whether they are getting tested or treated at a facility other than a cancer center, and perhaps most importantly, note the authors, how AYAs perceive their current quality of life.
“These patients have the potential to live a normal lifespan, and we need to educate them to become their own advocates so they may receive follow-up care on a regular basis,” said Dr. Beaupin. “We hope they continue to receive that follow-up at an established cancer center that has the facilities to assess cardiac health and provide rehabilitation if needed. There are now established survivorship programs nationwide that can provide follow-up care for those who have completed treatment.”
The researchers would like to have access to larger databases such as those maintained by health insurance providers in order to conduct more comprehensive studies. They are currently in contact with several providers to determine if there is a secure way to obtain those data.
This study was supported by funding from the National Cancer Institute of the National Institutes of Health.
View the full abstract.
For your readers:
2018 Cancer Survivorship Symposium News Planning Team:
Lewis E. Foxhall, MD, FAAP, American Academy of Family Physicians (AAFP); Carol A Rosenberg, MD, FACP, American College of Physicians (ACP); and Timothy D. Gilligan, MD, MSc, FASCO, American Society of Clinical Oncology (ASCO).
Click here to view the disclosures for the News Planning Team.
ATTRIBUTION TO THE 2018 CANCER SURVIVORSHIP SYMPOSIUM IS REQUESTED IN ALL NEWS COVERAGE.
About the American Academy of Family Physicians:
The American Academy of Family Physicians (AAFP) and its chapters represent more than 129,000 family physician, resident, and medical student members. The organization assists family practices in improving the health of patients, families, and communities by advancing the specialty of family medicine. Visit aafp.org to learn more.
About the American College of Physicians:
The American College of Physicians (ACP) has 152,000 members, including internists, internal medicine subspecialists, and medical students, residents, and fellows. The organization is the largest medical-specialty organization and second-largest physician group in the United States and is dedicated to helping apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults. To learn more, visit acponline.org.
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents nearly 45,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.